Ameritas Investment Partners, Inc. Eloxx Pharmaceuticals, Inc. Transaction History

Ameritas Investment Partners, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 06, 2021	SELL	$1.35 - $3.36 $3,006 - $7,482	-2,227 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$8.75 - $23.27 $19,486 - $51,822	2,227 New	2,227 $38,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Market Cap $66.7M
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.